Signal
Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, the FDA's approval letter for the oral treatment shows lingering reservations...
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-04-14 20:28 UTCUpdated 2026-04-15 09:34 UTC
rss
foundayo_fierce_pharma
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
FDA seeks safety data for Lilly's oral GLP-1 Foundayo Phil.Taylor Wed, 15/04/2026 - 09:34.
Score total
0.98
Momentum 24h
2
Posts
2
Origins
2
Source types
1
Duplicate ratio
0%
All evidence
All evidence
FDA seeks safety data for Lilly's oral GLP-1 Foundayo
pharmaphorum · pharmaphorum.com · 2026-04-15 09:34 UTC
Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, the FDA's approval letter for the oral treatment shows lingering reservations about multiple "une...
Fierce Pharma (All) · fiercepharma.com · 2026-04-14 20:28 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- pharmaphorum (1)
- Fierce Pharma (All) (1)
Top origin domains (this list)
- pharmaphorum.com (1)
- fiercepharma.com (1)